Variability in duration of outpatient diuretic therapy in bronchopulmonary dysplasia: A clinical experience

American Journal of Perinatology

Volumn 27, Issue 7, 2010, Pages 529-535

  Bhandari, Anita ^a,c   Chow, Urey ^b   Hagadorn, James I ^a,c  

^a Division of Infectious Diseases and Immunology   (United States)

^b TRINITY COLLEGE   (United States)

^c UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

Author keywords

Chronic lung disease; infants; spironolactone; thiazides

Indexed keywords

BRONCHODILATING AGENT; CHLOROTHIAZIDE; DIURETIC AGENT; FUROSEMIDE; SPIRONOLACTONE; STEROID;

AFRICAN AMERICAN; ARTICLE; BIRTH WEIGHT; CHROMOSOME ABERRATION; DIURETIC THERAPY; FEMALE; GESTATIONAL AGE; HEART DISEASE; HUMAN; INFANT; LUNG DYSPLASIA; MAJOR CLINICAL STUDY; MALE; OUTPATIENT CARE; PRIORITY JOURNAL; TRACHEOSTOMY; TREATMENT DURATION; AMBULATORY CARE; BRONCHOPULMONARY DYSPLASIA; MULTIVARIATE ANALYSIS; NEWBORN; OXIMETRY; OXYGEN THERAPY; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY;

AMBULATORY CARE; BRONCHOPULMONARY DYSPLASIA; CHLOROTHIAZIDE; DIURETICS; FEMALE; HUMANS; INFANT, NEWBORN; MALE; MULTIVARIATE ANALYSIS; OXIMETRY; OXYGEN INHALATION THERAPY; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES;

EID: 77954874286     PISSN: 07351631     EISSN: 10988785     Source Type: Journal    
DOI: 10.1055/s-0030-1248939     Document Type: Article

References (18)

1. McCann E M., Lewis K, Deming D D., Donovan M J., Brady J P. Controlled trial of furosemide therapy in infants with chronic lung disease. J Pediatr 1985 106 957-962
2. Clark R H., Bloom B T., Spitzer A R., Gerstmann D R. Reported medication use in the neonatal intensive care unit: data from a large national data set. Pediatrics 2006 117 1979-1987
3. Brion L P., Primhak R A., Ambrosio-Perez I. Diuretics acting on the distal renal tubule for preterm infants with (or developing) chronic lung disease. Cochrane Database Syst Rev 2002 (1) CD001817
4. Van Marter L J. Epidemiology of bronchopulmonary dysplasia. Semin Fetal Neonatal Med 2009 14 358-366
5. Madan A, Brozanski B S., Cole C H., Oden N L., Cohen G, Phelps D L. A pulmonary score for assessing the severity of neonatal chronic lung disease. Pediatrics 2005 115 e450-e457
6. Hussain N, Kimble C., Pappagallo M. Stress oximetry: a useful test for predicting discontinuation of supplemental oxygen in infants with BPD. Am J Respir Crit Care Med 2002 165 A645
7. Bancalari E, Wilson-Costello D, Iben S C. Management of infants with bronchopulmonary dysplasia in North America. Early Hum Dev 2005 81 171-179
8. Christou H, Brodsky D. Lung injury and bronchopulmonary dysplasia in newborn infants. J Intensive Care Med 2005 20 76-87
9. Tin W, Wiswell T E. Adjunctive therapies in chronic lung disease: examining the evidence. Semin Fetal Neonatal Med 2008 13 44-52
10. Kao L C., Warburton D, Sargent C W., Platzker A C., Keens T G. Furosemide acutely decreases airways resistance in chronic bronchopulmonary dysplasia. J Pediatr 1983 103 624-629
11. Kao L C., Warburton D, Cheng M H., Cedẽo C, Platzker A C., Keens T G. Effect of oral diuretics on pulmonary mechanics in infants with chronic bronchopulmonary dysplasia: results of a double-blind crossover sequential trial. Pediatrics 1984 74 37-44
12. Kao L C., Durand D J., Phillips B L., Nickerson B G. Oral theophylline and diuretics improve pulmonary mechanics in infants with bronchopulmonary dysplasia. J Pediatr 1987 111 439-444
13. Kao L C., Durand D J., Nickerson B G. Improving pulmonary function does not decrease oxygen consumption in infants with bronchopulmonary dysplasia. J Pediatr 1988 112 616-621
14. Engelhardt B, Elliott S, Hazinski T A. Short- and long-term effects of furosemide on lung function in infants with bronchopulmonary dysplasia. J Pediatr 1986 109 1034-1039
15. Kao L C., Durand D J., McCrea R C., Birch M, Powers R J., Nickerson B G. Randomized trial of long-term diuretic therapy for infants with oxygen-dependent bronchopulmonary dysplasia. J Pediatr 1994 124 (5 Pt 1) 772-781
16. Bhandari V, Bizzarro M J., Shetty A et al, Neonatal Genetics Study Group. Familial and genetic susceptibility to major neonatal morbidities in preterm twins. Pediatrics 2006 117 1901-1906
17. Lavoie P M., Pham C, Jang K L. Heritability of bronchopulmonary dysplasia, defined according to the consensus statement of the national institutes of health. Pediatrics 2008 122 479-485
18. Kwinta P, Bik-Multanowski M, Mitkowska Z, Tomasik T, Legutko M, Pietrzyk J J. Genetic risk factors of bronchopulmonary dysplasia. Pediatr Res 2008 64 682-688